JW Pharmaceutical (XKRX:001060) Long-Term Capital Lease Obligation : ₩22,419 Mil (As of Mar. 2024)

View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Long-Term Capital Lease Obligation?

JW Pharmaceutical's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩22,419 Mil.

JW Pharmaceutical's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (₩23,421 Mil) to Dec. 2023 (₩22,876 Mil) and declined from Dec. 2023 (₩22,876 Mil) to Mar. 2024 (₩22,419 Mil).

JW Pharmaceutical's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (₩1,326 Mil) to Dec. 2022 (₩1,849 Mil) and increased from Dec. 2022 (₩1,849 Mil) to Dec. 2023 (₩22,876 Mil).

JW Pharmaceutical Long-Term Capital Lease Obligation Historical Data

The historical data trend for JW Pharmaceutical's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Long-Term Capital Lease Obligation Chart

JW Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

1,463.55

1,319.53

1,326.48

1,849.31

22,875.82

JW Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															29,555.72	23,988.33	23,420.67	22,875.82	22,419.33

JW Pharmaceutical (XKRX:001060) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

JW Pharmaceutical Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

JW Pharmaceutical (XKRX:001060) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

001067:Korea 001065.PFD:Korea

Address

2477, Nambusunhwan-ro, Seocho-gu, KOR

Website

https://www.jw-pharma.co.kr

JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical (XKRX:001060) Headlines

No Headlines